Related Experiment Video
Updated: May 15, 2026
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Self-regressing S100-negative CD1a-positive cutaneous histiocytosis
Juan C Tardío1, Marta Aguado, Jesús Borbujo
1Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. jtardio.hflr@salud.madrid.org
Insights
Researchers identified a rare skin histiocytosis with a unique CD1a-positive, S100 protein-negative profile. This finding may link to indeterminate dendritic cell tumors, but requires further study for classification and prognosis.
Area of Science:
- Dermatology
- Immunohistochemistry
- Oncology
Background:
- Cutaneous antigen-presenting cells (APCs) include Langerhans cells, indeterminate cells, and interstitial dendritic cells.
- These cells possess distinct immunophenotypes and ultrastructures.
- Histiocytosis involves abnormal proliferation of these cells.
Observation:
- A case of cutaneous-limited, self-regressing histiocytosis was observed.
- The lesion exhibited a peculiar immunohistochemical profile: CD1a-positive and S100 protein-negative.
- This specific immunophenotype is not recognized in known cutaneous APCs or neoplasms.
Findings:
- The reported histiocytosis presents a unique immunohistochemical signature.
- This profile differs from established classifications of cutaneous dendritic cell neoplasms.
- The lesion's characteristics suggest a potential relationship with indeterminate dendritic cell tumors.
Implications:
- Clarification of the nosologic position of this rare histiocytosis is needed.
- Further research is required to determine the clinical outcome and prognosis.
- This case expands the understanding of dendritic cell tumor spectrum and diagnostic challenges.
Abstract:
In the skin, the antigen-presenting cells are mainly represented by Langerhans cells, indeterminate cells, and interstitial dendritic cells, which show distinctive immunophenotype and/or ultrastructure. We report a case of a cutaneous-limited self-regressing histiocytosis with a peculiar immunohistochemical profile (CD1a-positive and S100 protein-negative) that is not observed in any of the known cutaneous antigen-presenting cell or nowadays recognized neoplasm. This lesion is probably related to indeterminate dendritic cell tumors, but very few cases with such immunoprofile have been reported up-to-date, and their exact nosologic position and outcome remain to be clarified.
